Jully Oyama

Jully Oyama

Auto-generated profile, based on publicly available information

Jully Oyama

Program in Auditing in Health Services, Assis Gurgacz Foundation University Center

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2018 in Photodiagnosis and Photodynamic Therapy
Verified
Journal Article
Closed access
VNVanessa Nesi-Reis
Vanessa Nesi-Reis
DLDaniele Stéfanie Sara Lopes Lera-Nonose
Daniele Stéfanie Sara Lopes Lera-Nonose
JOJully Oyama
Jully Oyama
MLMarielle Priscila De Paula Silva Lalucci
Marielle Priscila De Paula Silva Lalucci
IDIZABEL GALHARDO DEMARCHI
IZABEL GALHARDO DEMARCHI
MLMaria Valdrinez Campana Lonardoni
Maria Valdrinez Campana Lonardoni

1 June 2020 in Photodiagnosis and Photodynamic Therapy
Verified
Journal Article
Closed access
JOJully Oyama
Jully Oyama
ÁRÁquila Carolina Fernandes Herculano Ramos-Milaré
Áquila Carolina Fernandes Herculano Ramos-Milaré
DLDaniele Stéfanie Sara Lopes Lera-Nonose
Daniele Stéfanie Sara Lopes Lera-Nonose
VNVanessa Nesi-Reis
Vanessa Nesi-Reis
IDIzabel Galhardo Demarchi
Izabel Galhardo Demarchi
MLMaria Valdrinez Campana Lonardoni
Maria Valdrinez Campana Lonardoni

3 August 2020 in Parasitology
Verified
Journal Article
Closed access
PDF file
CSCélia Eliane de Lara da Silva
Célia Eliane de Lara da Silva
JOJully Oyama
Jully Oyama
FFFabiana Borges Padilha Ferreira
Fabiana Borges Padilha Ferreira
MSMarielle Priscila de Paula Silva
Marielle Priscila de Paula Silva
TLTarcísio Vitor Augusto Lordani
Tarcísio Vitor Augusto Lordani
MLMaria Valdrinez Campana Lonardoni
Maria Valdrinez Campana Lonardoni
This systematic review investigated the evidence for the therapeutic potential of essential oils (EOs) against Leishmania amazonensis. We searched available scientific publications from 2005 to 2019 in the PubMed and Web of Science electronic databases, according to PRISMA statement. The search strategy utilized descriptors and free terms. The EOs effect of 35 species of plants identified in this systematic review study, 45.7% had half of the maximal inhibitory concentration (IC50) 10 < IC50 ⩽ 50 μg mL−1 and 14.3% had a 10 < IC50μg mL−1 for promastigote forms of L. amazonensis. EOs from Cymbopogon citratus species had the lowest IC50 (1.7 μg mL−1). Among the plant species analyzed for activity against intracellular amastigote forms of L. amazonensis, 39.4% had an IC50 10 < IC50 ⩽ 50 μg mL−1, and 33.3% had an IC50 10 < IC50μg mL−1. Aloysia gratissima EO showed the lowest IC50 (0.16 μg mL−1) for intracellular amastigotes. EOs of Chenopodium ambrosioides, Copaifera martii and Carapa guianensis, administered by the oral route, were effective in reducing parasitic load and lesion volume in L. amazonensis-infected BALB/c mice. EOs of Bixa orellana and C. ambrosioides were effective when administered intraperitoneally. Most of the studies analyzed in vitro and in vivo for the risk of bias showed moderate methodological quality. These results indicate a stimulus for the development of new phytotherapy drugs for leishmaniasis treatment.

1 April 2019 in Acta Tropica
Verified
Journal Article
Closed access
JOJully Oyama
Jully Oyama
DLDaniele Stéfanie Sara Lopes Lera-Nonose
Daniele Stéfanie Sara Lopes Lera-Nonose
ÁRÁquila Carolina Fernandes Herculano Ramos-Milaré
Áquila Carolina Fernandes Herculano Ramos-Milaré
FFFabiana Borges Padilha Ferreira
Fabiana Borges Padilha Ferreira
CFCamila Fabiano de Freitas
Camila Fabiano de Freitas
MLMaria Valdrinez Campana Lonardoni
Maria Valdrinez Campana Lonardoni

15 February 2018 in Revista do Instituto de Medicina Tropical de São Paulo
Verified
Journal Article
Open access
PDF file
JOJully Oyama
Jully Oyama
FFFabiana Borges Padilha Ferreira
Fabiana Borges Padilha Ferreira
CCCarolina Cella Conter
Carolina Cella Conter
DLDaniele Stéfanie Sara Lopes Lera-Nonose
Daniele Stéfanie Sara Lopes Lera-Nonose
ÁRÁquila Carolina Fernandes Herculano Ramos-Milaré
Áquila Carolina Fernandes Herculano Ramos-Milaré
MLMaria Valdrinez Campana Lonardoni
Maria Valdrinez Campana Lonardoni
This clinical case presents a patient with a raised and ulcerative lesion with erythematous edges in the mouth, on the lower lip that was unsuccessfully treated as herpes labialis. Clinical data and laboratory tests (Montenegro skin test, indirect immunofluorescence, direct parasite search and polymerase chain reaction) led to the diagnosis of American tegumentary leishmaniasis caused by Leishmania (Viannia) sp. Treatment with pentavalent antimonial (Glucantime®) for 120 days was not effective and administration of amphotericin B for 30 days resulted in wound healing. Glucantime® treatment protocol was longer than the recommended by the Brazilian Ministry of Health in the handbook of mucosal leishmaniasis. This suggests that amphotericin B should have been administered earlier, preventing the psychological and social problems faced by the patient. This study reports a rare clinical case of primary mucosal leishmaniasis on the lip that had a delayed diagnosis, highlighting the precariousness in the management of disease and showing that, despite the importance of leishmaniasis in Brazil, it is still neglected by health professionals.

30 September 2013 in O Mundo da Saúde
Verified
Journal Article
Closed access
MYMirian Ueda Yamaguchi
Mirian Ueda Yamaguchi
LCLúcia Elaine Ranieri Cortez
Lúcia Elaine Ranieri Cortez
LOLilian Cristina Camargo Ottoni
Lilian Cristina Camargo Ottoni
JOJully Oyama
Jully Oyama